Literature DB >> 16487046

LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins.

Qunxing Ding1, Sarah Martin, Edgardo Dimayuga, Annadora J Bruce-Keller, Jeffrey N Keller.   

Abstract

The proteasome is a large intracellular protease, composed of multiple subunits, that is present in all eukaryotic cells. Proteasome inhibition is known to occur during normal aging, and is believed to contribute towards an age-related increase in oxidative stress, although at present the mechanisms responsible for mediating age-related changes in proteasome activity have not been elucidated. At present the relationship between proteasome subunit expression, proteasome activity, and protein oxidation during normal aging has not been elucidated. In the present study we observed that the absence of LMP2, a specific proteasome subunit, decreases proteasome activities in both the brain and liver, with increased levels of protein oxidation occurring in both tissues. Results from this study demonstrate for the first time that individual proteasome subunits are important for the regulation of age-related changes in both proteasome activity and protein oxidation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487046     DOI: 10.1089/ars.2006.8.130

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  26 in total

1.  Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules.

Authors:  Benoît Guillaume; Jacques Chapiro; Vincent Stroobant; Didier Colau; Benoît Van Holle; Grégory Parvizi; Marie-Pierre Bousquet-Dubouch; Ivan Théate; Nicolas Parmentier; Benoît J Van den Eynde
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

Review 2.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Immunoproteasome responds to injury in the retina and brain.

Authors:  Deborah A Ferrington; Stacy A Hussong; Heidi Roehrich; Rebecca J Kapphahn; Shannon M Kavanaugh; Neal D Heuss; Dale S Gregerson
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

4.  Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction.

Authors:  Kalavathi Dasuri; Anhthao Nguyen; Le Zhang; Ok Sun Fernandez-Kim; Annadora J Bruce-Keller; Bradford A Blalock; Rafael De Cabo; Jeffrey N Keller
Journal:  Free Radic Res       Date:  2009-01

5.  Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency.

Authors:  Zheqing P Cai; Zhenyun Shen; Luc Van Kaer; Lewis C Becker
Journal:  FASEB J       Date:  2008-08-26       Impact factor: 5.191

Review 6.  Oxidative stress-mediated regulation of proteasome complexes.

Authors:  Charity T Aiken; Robyn M Kaake; Xiaorong Wang; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2011-05       Impact factor: 5.911

Review 7.  Emerging roles of immunoproteasomes beyond MHC class I antigen processing.

Authors:  Frédéric Ebstein; Peter-Michael Kloetzel; Elke Krüger; Ulrike Seifert
Journal:  Cell Mol Life Sci       Date:  2012-03-02       Impact factor: 9.261

8.  IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism.

Authors:  Pavel Kopach; Virginia Lockatell; Edward M Pickering; Ronald E Haskell; Richard D Anderson; Jeffrey D Hasday; Nevins W Todd; Irina G Luzina; Sergei P Atamas
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

9.  Transformation of the proteasome with age-related macular degeneration.

Authors:  Cheryl M Ethen; Stacy A Hussong; Cavan Reilly; Xiao Feng; Timothy W Olsen; Deborah A Ferrington
Journal:  FEBS Lett       Date:  2007-02-02       Impact factor: 4.124

Review 10.  The ubiquitin-proteasome system in retinal health and disease.

Authors:  Laura Campello; Julián Esteve-Rudd; Nicolás Cuenca; José Martín-Nieto
Journal:  Mol Neurobiol       Date:  2013-01-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.